You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Ferric derisomaltose - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for ferric derisomaltose and what is the scope of freedom to operate?

Ferric derisomaltose is the generic ingredient in one branded drug marketed by Pharmacosmos and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric derisomaltose has fifty-nine patent family members in twenty-five countries.

One supplier is listed for this compound.

Summary for ferric derisomaltose
International Patents:59
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 5
Clinical Trials: 22
Patent Applications: 6
What excipients (inactive ingredients) are in ferric derisomaltose?ferric derisomaltose excipients list
DailyMed Link:ferric derisomaltose at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ferric derisomaltose
Generic Entry Date for ferric derisomaltose*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for ferric derisomaltose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Hospital Los AngelesPhase 4
China-Japan Friendship HospitalPhase 4
Oregon Health and Science UniversityEarly Phase 1

See all ferric derisomaltose clinical trials

US Patents and Regulatory Information for ferric derisomaltose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-001 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-003 Jan 16, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmacosmos MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ferric derisomaltose

Country Patent Number Title Estimated Expiration
European Patent Office 3310364 COMPLEXE FERREUX DE GLUCIDE POUR LE TRAITEMENT D'UNE CARENCE EN FER D'UN FOETUS OU NOURRISSON (IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF IRON DEFICIENCY OF A FETUS OR AN INFANT) ⤷  Sign Up
South Africa 201107431 A STABLE IRON OLIGOSACCHARIDE COMPOUND ⤷  Sign Up
Croatia P20170230 ⤷  Sign Up
Japan 2021011487 胎児又は小児の鉄欠乏症の治療のための鉄炭水化物複合体 (IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF IRON DEFICIENCY OF FETUS OR INFANT) ⤷  Sign Up
Portugal 3156075 ⤷  Sign Up
Denmark 3156075 ⤷  Sign Up
China 116898874 用于治疗胎儿或婴儿铁缺乏的铁碳水化合物复合物 (Iron carbohydrate complexes for treatment of iron deficiency in fetuses or infants) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ferric derisomaltose

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2411053 C02411053/01 Switzerland ⤷  Sign Up PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.